Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs MANGALAM DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA MANGALAM DRUGS SHUKRA PHARMA/
MANGALAM DRUGS
 
P/E (TTM) x 19.3 -8.6 - View Chart
P/BV x 14.1 1.0 1,464.3% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   MANGALAM DRUGS
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
MANGALAM DRUGS
Mar-23
SHUKRA PHARMA/
MANGALAM DRUGS
5-Yr Chart
Click to enlarge
High Rs89173 51.4%   
Low Rs1195 11.7%   
Sales per share (Unadj.) Rs53.7235.2 22.8%  
Earnings per share (Unadj.) Rs4.00.8 501.2%  
Cash flow per share (Unadj.) Rs5.77.7 73.6%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.196.0 24.0%  
Shares outstanding (eoy) m10.9615.83 69.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.90.6 163.4%   
Avg P/E ratio x12.4166.8 7.4%  
P/CF ratio (eoy) x8.817.3 50.7%  
Price / Book Value ratio x2.21.4 155.1%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m5472,118 25.8%   
No. of employees `000NANA-   
Total wages/salary Rs m44346 12.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5883,723 15.8%  
Other income Rs m124 274.5%   
Total revenues Rs m6003,727 16.1%   
Gross profit Rs m54255 21.0%  
Depreciation Rs m18110 16.7%   
Interest Rs m3128 2.2%   
Profit before tax Rs m4422 200.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m09 3.7%   
Profit after tax Rs m4413 347.0%  
Gross profit margin %9.16.9 133.0%  
Effective tax rate %0.842.6 1.9%   
Net profit margin %7.50.3 2,195.3%  
BALANCE SHEET DATA
Current assets Rs m5312,066 25.7%   
Current liabilities Rs m4251,654 25.7%   
Net working cap to sales %18.011.1 162.2%  
Current ratio x1.21.2 99.9%  
Inventory Days Days01 0.0%  
Debtors Days Days1,873456 410.5%  
Net fixed assets Rs m2191,530 14.3%   
Share capital Rs m39158 24.7%   
"Free" reserves Rs m2141,361 15.7%   
Net worth Rs m2531,520 16.6%   
Long term debt Rs m38188 20.1%   
Total assets Rs m7503,596 20.8%  
Interest coverage x16.81.2 1,432.1%   
Debt to equity ratio x0.10.1 120.6%  
Sales to assets ratio x0.81.0 75.8%   
Return on assets %6.33.9 160.4%  
Return on equity %17.40.8 2,084.2%  
Return on capital %16.28.8 185.4%  
Exports to sales %00-   
Imports to sales %025.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA958 0.0%   
Fx inflow Rs m01,078 0.0%   
Fx outflow Rs m0978 0.0%   
Net fx Rs m0100 0.0%   
CASH FLOW
From Operations Rs m32395 8.0%  
From Investments Rs m-44-222 20.0%  
From Financial Activity Rs m49-166 -29.7%  
Net Cashflow Rs m377 501.9%  

Share Holding

Indian Promoters % 51.0 50.3 101.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.1 110.0%  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 49.7 98.7%  
Shareholders   10,963 18,610 58.9%  
Pledged promoter(s) holding % 0.0 18.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs MANGALAM DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs MANGALAM DRUGS Share Price Performance

Period RELISH PHARMA MANGALAM DRUGS S&P BSE HEALTHCARE
1-Day -2.00% -1.17% 1.18%
1-Month 18.32% -23.18% -0.75%
1-Year 528.10% -7.12% 61.82%
3-Year CAGR 229.50% -3.92% 18.16%
5-Year CAGR 114.18% 10.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the MANGALAM DRUGS share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of MANGALAM DRUGS the stake stands at 50.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of MANGALAM DRUGS.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

MANGALAM DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of MANGALAM DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.